Swift Street Capital
Venture capitalActively deployingDurham · Seed–Series A · 2 people tracked
Investment thesis
Swift Street Capital believes healthcare is undergoing fundamental transformation driven by aging populations, rising longevity expectations, and technological breakthroughs in diagnosis and disease management. Large incumbent healthcare companies struggle to innovate at speed and increasingly rely on acquisitions, creating opportunities for venture-backed companies. Entrepreneurial physicians with clinical insight and market awareness are uniquely positioned to identify next-generation health companies before the broader market. Additionally, generative AI is lowering the cost and complexity of building technology companies, amplifying returns for early investors. This combination of overlooked opportunities from research institutions in underserved capital markets and the physician-led advantage creates a compelling investment environment.
Source: firm website, verified Jul 21, 2026.
Team · 2 people
from the firm's websiteProfessor of Surgery at Duke University with over two decades of clinical practice and research in vascular surgery. Founded and served as CEO of Humacyte Inc. (NASDAQ: HUMA) and Innavasc Inc., which sold to Gore Medical with a 10x return. Currently President and CEO of MedBlue Incubator. Holds an MD and PhD in Cellular and Molecular Biology from the University of Vermont.
Pediatric cardiologist with over two decades of clinical practice and served as Chair of Pediatrics. Chief Operating Officer of MedBlue Incubator and Adjunct Professor at Duke University Fuqua School of Business. Holds leadership positions in medical officer roles across multiple health ventures and is an investor with Ariel Southeast Angel Partners. Earned an MD, MBA, and BA in Economics from Duke University.
Frequently asked questions
- What stage does Swift Street Capital invest at?
- Swift Street Capital invests at the Seed, Series A stages.
- What sectors does Swift Street Capital focus on?
- Swift Street Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Swift Street Capital located?
- Swift Street Capital is headquartered in Durham, US.
Images
Similar investors
A venture capital firm partnering with pre-seed and seed stage founders addressing major global challenges. The firm provides hands-on support across business launch, go-to-market strategy, fundraising, and marketing.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.